Empasov, containing the active ingredient Empagliflozin, is a medication used primarily for the management of type 2 diabetes. It belongs to the class of drugs known as SGLT2 inhibitors, which work by helping the kidneys remove glucose from the bloodstream, thereby lowering blood sugar levels.
Empagliflozin functions by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys. This action prevents glucose reabsorption and promotes its excretion through urine. As a result, it helps in controlling blood sugar levels in patients with type 2 diabetes.
Empasov is typically taken once daily, with or without food. It is essential to follow your healthcare provider's instructions regarding dosage and administration. Regular monitoring of blood sugar levels is recommended to assess the effectiveness of the treatment.
Common side effects may include:
Consult your healthcare provider if you experience severe side effects or signs of an allergic reaction.
Before starting Empasov, inform your healthcare provider about any medical conditions, allergies, or medications you are currently taking. It is not recommended for individuals with severe kidney problems or those on dialysis.
Empasov (Empagliflozin) is an effective treatment option for managing type 2 diabetes, offering additional cardiovascular benefits. Always consult with your healthcare provider for personalized medical advice and to determine if Empasov is right for you.